About 200 reports

The Global Castrate-resistant Prostate Cancer Market size is expected to reach $14.5 billion by 2026, rising at a market growth of 8.3% CAGR during the forecast period. Castrate-resistant Prostate Cancer (CRPC), a variety of prostate cancer that generally recurs after managing androgen deprivation therapy (ADC), is getting prominent in the...

  • Prostate Cancer
  • World
  • APAC
  • North America
  • Europe
  • Drug Approval
  • Health Expenditure

Major players in the prostate cancer drugs market are Astellas Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, Bayer AG, Roche, Abbott, Pfizer, Norvaris and F. Hoffmann-La Roche AG. The global prostate cancer drugs market is expected to grow from $16.09 billion in 2021 to $17.64 billion in 2022 at a compound annual growth rate...

  • Prostate Cancer
  • World
  • United States
  • Drug Approval

Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Drugs In Development, 2021, provides an overview of the Prostate Cancer (Oncology) pipeline landscape. Prostate cancer is a form of cancer that...

  • Prostate Cancer
  • World

Prostate Cancer Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Prostate Cancer Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Prostate Cancer Devices types, applications. Further,...

  • Prostate Cancer
  • World

Castrate Resistant Prostate Cancer Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Castrate Resistant Prostate Cancer Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Castrate...

  • Prostate Cancer
  • World

Major players in the prostate cancer drugs market are Astellas Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, and Bayer AG. The global prostate cancer drugs market is expected to grow from $3.65 billion in 2020 to $3.87 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth is mainly due to the companies rearranging...

  • Prostate Cancer
  • World
  • United States
  • Drug Approval

Castrate Resistant Prostate Cancer Therapeutics Market Report Overview Castrate Resistant Prostate Cancer Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Castrate Resistant Prostate Cancer Therapeutics market types and...

  • Prostate Cancer
  • World
  • Health Provider Density

Abstract: - Global Prostate Cancer Diagnostics Market to Reach $6.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Prostate Cancer Diagnostics estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$6.8 Billion by 2027, growing at aCAGR of 11.9% over the period 2020-2027....

  • Prostate Cancer
  • Diagnostics
  • World
  • China
  • United States

China’s demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...

  • Prostate Cancer
  • Hormone
  • China
  • Industrial Production
  • Labour Force

Abstract: - Global Prostate Cancer Therapeutics Market to Reach $24.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Prostate Cancer Therapeutics estimated at US$16.1 Billion in the year 2020, is projected to reach a revised size of US$24.8 Billion by 2027, growing at a CAGR of 6.4% over the analysis...

  • Prostate Cancer
  • Chemotherapy
  • World
  • China
  • United States

Prostate Cancer - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Pipeline Review, H2 2020, provides an overview of the Prostate Cancer (Oncology) pipeline landscape. Prostate cancer is a form of cancer that affects men and...

  • Prostate Cancer
  • World

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Prostate Cancer Diagnostic Tests pipeline products with...

  • Prostate Cancer

Abstract: - Global Oncology Molecular Diagnostics Market to Reach $3.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Oncology Molecular Diagnostics estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$3.6 Billion by 2027, growing at a CAGR of 11.2% over the analysis...

  • Molecular Diagnostics
  • Prostate Cancer
  • World
  • China
  • United States

The prostate cancer nuclear medicine diagnostics market in the US was valued at US$ 194.47 million in 2019 and is expected to grow at a CAGR of 10.6% from 2020 to 2027 to reach US$ 431.76 million by 2027. Driving factors of the prostate cancer nuclear medicine diagnostics market are rising prevalence of prostate cancer and the growth of...

  • Prostate Cancer
  • Diagnostics
  • United States
  • Diagnostic Imaging Density
  • Diagnostic Revenue

Castrate-resistant Prostate Cancer Market Size, Share & Trends Analysis Report By Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy), By Region, And Segment Forecasts, 2020 - 2027 Castrate-resistant Prostate Cancer Market Growth & Trends The global castrate-resistant prostate...

  • Prostate Cancer
  • World
  • APAC
  • Europe
  • United States
  • Health Expenditure

"US Prostate Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • US Prostate Cancer Drug Market Opportunity: > US$ 4 Billion • Comprehensive Clinical Insight On 25 FDA Approved Prostate Cancer Drugs • Drug Dosage, Patent, Price, Patent Insight • Insight On 222...

  • Prostate Cancer
  • United States
  • World
  • Mortality Rate

Hormone-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Hormone-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Hormone-Sensitive Prostate Cancer pipeline landscape. The report provides comprehensive information on the...

  • Prostate Cancer
  • World

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Prostate Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Prostate Cancer
  • World

Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Androgen-Sensitive Prostate Cancer pipeline landscape. The report provides comprehensive information on...

  • Prostate Cancer
  • World

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Hormone Refractory (Castration...

  • Prostate Cancer
  • Hormone
  • World

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the...

  • Prostate Cancer
  • Hormone
  • World

Prostate Cancer Diagnostics Market Global Forecast By Type (Preliminary Screening, Confirmatory Test, PCA3, Trans-rectal Ultrasound, Biopsy), End Users, Regions, Company Analysis Early detection and treatment that improves survival chances is a paradigm in cancer treatment. Cancer, especially prostate...

  • Prostate Cancer
  • Diagnostics
  • World

Prostate Specific Antigen - Pipeline Review, H1 2020 Summary Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Prostate-specific antigen (PSA) is a glycoprotein enzyme encoded by the KLK3 gene. PSA is secreted by the epithelial...

  • Prostate Cancer
  • World
  • Northern Europe
  • Drug Approval
  • Lead Price

“Lutetium-177 (Lu-177) Global Market and Pipeline Analysis – Forecast to 2028” gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of developed for the treatment of prostate cancer, NETs, Lung cancer, solid tumors and other conditions. The report covers marketed products...

  • Prostate Cancer
  • Monoclonal Antibody
  • World

Prostate Specific Antigen - Pipeline Review, H2 2020 Summary According to the recently published report ’Prostate Specific Antigen - Pipeline Review, H2 2020’; Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) pipeline Target...

  • Prostate Cancer
  • World
  • Northern Europe
  • United Kingdom
  • Drug Approval
  • Lead Price

Prostate Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H1 2020, provides an overview of the Prostate Cancer (Oncology) pipeline landscape. Prostate cancer is a form of cancer that affects men...

  • Prostate Cancer
  • World

The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. By...

  • Healthcare
  • In Vitro Diagnostics
  • Pharmaceutical
  • Hospital
  • Breast Cancer
  • Biotechnology
  • Infectious Disease
  • Prostate Cancer
  • Neurodegenerative Disease
  • Cardiovascular Disease
  • Lung Cancer
  • World
  • North America
  • Europe
  • APAC
  • Cancer Incidence
  • Disposable Income

Chile Radiotherapy Market Size, Share & Trends Analysis Report By Type (External Beam, Internal Beam, Systemic Radiotherapy), By Application (Breast, Prostate, Lung, Colorectal, Head & Neck Cancer), And Segment Forecasts, 2021 - 2028 Chile Radiotherapy Market Growth & Trends The Chile radiotherapy...

  • Oncology
  • Healthcare
  • Lung Cancer
  • Prostate Cancer
  • Chile
  • Cancer Incidence
  • Health Expenditure

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drugs in Development, 2021 Summary Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) pipeline Target constitutes close to 9 molecules. Out of which approximately...

  • Pharmaceutical
  • Cancer
  • Oncology
  • Prostate Cancer
  • World
  • Drug Approval

Glutamate Carboxypeptidase 2 - Pipeline Review, H2 2019 Summary According to the recently published report ’Glutamate Carboxypeptidase 2 - Pipeline Review, H2 2019’; Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase...

  • Prostate Cancer
  • Pharmaceutical
  • Renal Cancer
  • World
  • Pharmaceutical Registrations